Microbubble contrast agents: a new era in ultrasound
暂无分享,去创建一个
D O Cosgrove | D. Cosgrove | E. Unger | M. Monaghan | M. Blomley | M J Blomley | E C Unger | M J Monaghan | J C Cooke | J. Cooke | Jennifer C Cooke | Evan C Unger | Mark J Monaghan | David O Cosgrove
[1] B. Choi,et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. , 2000, Radiology.
[2] R V Shohet,et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. , 2000, Circulation.
[3] Morton W. Miller,et al. Gene transfection and drug delivery. , 2000, Ultrasound in medicine & biology.
[4] H. Dittrich,et al. Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material. , 2000, American heart journal.
[5] J G Miller,et al. Contrast Echocardiography: Current and Future Applications , 2000 .
[6] D. Cosgrove,et al. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases , 2000, The Lancet.
[7] D O Cosgrove,et al. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. , 1999, Ultrasound in medicine & biology.
[8] T. Bourne,et al. The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X‐ray hysterosalpingography for the investigation of infertility patients , 1999, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[9] K Moehring,et al. Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethrography for diagnosis. , 1999, Radiology.
[10] Thomas Albrecht,et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent , 1999, The Lancet.
[11] D O Cosgrove,et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. , 1999, Radiology.
[12] P. Steg,et al. Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: relation to timing and extent of functional recovery , 1999, Heart.
[13] B. Goldberg,et al. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. , 1999, Radiology.
[14] S. Taylor-Robinson,et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. , 1998, Radiology.
[15] Y Wu,et al. Binding and lysing of blood clots using MRX-408. , 1998, Investigative radiology.
[16] T C Skalak,et al. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. , 1998, Circulation.
[17] D S Segar,et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. , 1998, Journal of the American College of Cardiology.
[18] S. Feinstein,et al. Contrast echocardiography: review and future directions. , 1998, The American journal of cardiology.
[19] D O Cosgrove,et al. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. , 1998, Radiology.
[20] J. Ruskin,et al. Nonpharmacologic therapies for atrial fibrillation. , 1998, The American journal of cardiology.
[21] J. Butler,et al. Frequency of low-risk hospital admissions for heart failure. , 1998, The American journal of cardiology.
[22] S. Russell,et al. Science, medicine, and the future : Gene therapy , 1997, BMJ.
[23] Edwin L. Carstensen,et al. Echo-enhancing agents: safety , 1997 .
[24] P. Iversen,et al. Interaction of diagnostic ultrasound with synthetic oligonucleotide‐labeled perfluorocarbon‐exposed sonicated dextrose albumin microbubbles. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[25] D. Cosgrove. Why do we need contrast agents for ultrasound? , 1996, Clinical radiology.
[26] R. Nakielny,et al. Temporomandibular joint imaging. , 1996, Clinical radiology.
[27] R. Schlief,et al. A Transpulmonary Contrast Medium Enhances the Transcranial Doppler Signal in Humans , 1993, Stroke.
[28] R. Apfel,et al. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. , 1991, Ultrasound in medicine & biology.